Solace Pharmaceuticals Inc. Lands $6,749,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0a546084-dd3e-4742-ae5f-5b4928fd7810&Preview=1
Date
3/31/2008
Company Name
Solace Pharmaceuticals Inc.
Mailing Address
222 Berkeley Street Boston, MA 02116
Company Description
Solace was co-founded in March 2006 by PureTech Ventures and a preeminent team of scientific, clinical, regulatory and drug development experts who are collaborating to translate groundbreaking scientific discoveries in pain biology into innovative, effective therapeutic strategies for addressing chronic pain. Solace Pharmaceuticals is developing innovative therapies for treating chronic pain based on recent groundbreaking scientific discoveries. The company has promising programs at varying stages of preclinical and clinical development in its pipeline.
Website
http://www.solacepharma.com
Transaction Type
Venture Equity
Transaction Amount
$6,749,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
InterWest Partners
Venture Investor
Polaris Venture Partners